Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

about

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

Item

http://www.wikidata.org/entity/Q58793373

description

im Oktober 2018 veröffentlicher wissenschaftlicher Artikel

@de

scientific article published on 13 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Determinants of ovarian functi ...... of a randomised phase 3 trial

@en

Determinants of ovarian functi ...... th advanced Hodgkin's lymphoma

@nl

type

Item

label

Determinants of ovarian functi ...... of a randomised phase 3 trial

@en

Determinants of ovarian functi ...... th advanced Hodgkin's lymphoma

@nl

prefLabel

Determinants of ovarian functi ...... of a randomised phase 3 trial

@en

Determinants of ovarian functi ...... th advanced Hodgkin's lymphoma

@nl

P1476

Determinants of ovarian functi ...... of a randomised phase 3 trial

@en

P2093

Amy A Kirkwood

http://www.w3.org/2001/XMLSchema#string

Chris Hatton

http://www.w3.org/2001/XMLSchema#string

Clare Rowntree

http://www.w3.org/2001/XMLSchema#string

Don W Milligan

http://www.w3.org/2001/XMLSchema#string

Fiona M Scott

http://www.w3.org/2001/XMLSchema#string

Laura Clifton-Hadley

http://www.w3.org/2001/XMLSchema#string

Linsey Stevens

http://www.w3.org/2001/XMLSchema#string

Nagesh Kalakonda

http://www.w3.org/2001/XMLSchema#string

Pam McKay

http://www.w3.org/2001/XMLSchema#string

Pip Patrick

http://www.w3.org/2001/XMLSchema#string

P2860

Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram

Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review.

Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review.

ESHRE Guideline: management of women with premature ovarian insufficiency.

Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

P304

1328-1337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(18)30500-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter W Johnson

P577

2018-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30220622

http://www.w3.org/2001/XMLSchema#string

P932

6167406

http://www.w3.org/2001/XMLSchema#string